MANNHEIM, Germany (AP) — MANNHEIM, Germany (AP) — Affimed N.V. (AFMD) on Thursday reported a loss of $16.6 million in its second quarter.
The Mannheim, Germany-based company said it had a loss of $1.09 per share.
The results did not meet Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of $1 per share.
The drug developer posted revenue of $166,000 in the period.
The company's shares closed at $3.75. A year ago, they were trading at $5.38.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on AFMD at https://www.zacks.com/ap/AFMD
